Heavy weight! 93 key projects of Zhangjiang Science City were signed, and the headquarters of ImmuneOnco was listed as one of the key projects
On the morning of December 18, 2020, the signing and launching ceremony of key projects of Zhangjiang Science City will be held in Zhangjiang. Focusing on the online new economy, the event focused on the three major industries of integrated circuit, biomedicine and artificial intelligence, with 58 contracted projects, 35 started projects, and 93 projects, with a total investment of about 87 billion yuan.
The projects signed and launched this time involve science and technology finance, innovation and R&D platform, urban function improvement and other fields. It will continuously improve the innovation chain, industry chain and value chain, continuously promote the improvement of innovation policy source function and optimize business environment, and strive to achieve more breakthroughs from 0 to 1——
A number of industrial projects, such as ImmuneOnco, Chuanyin holding and Bayi spacetime, will further accelerate the agglomeration of key industries in Zhangjiang Science City and enhance the level of leading industries.
Zhangjiang online new economic Park, with a planning area of 4.1 square kilometers, is an important part of the construction of Pudong New Area's "golden central development belt". It will fully strengthen the advantages of Zhangjiang Science City in science and technology innovation, and strive to become the first choice of industry, talent pool and innovation furnace for online new economy, enabling Zhangjiang to develop digital economy.
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. was founded in June 2015 and registered in Zhangjiang High Tech Park, Shanghai. The company is mainly committed to the development and research of tumor immunotherapy products, including bispecific antibodies, new recombinant proteins, and TANKTM cell therapy. The common feature of our products is to stimulate and mobilize the immune system of patients to play an anti-tumor effect, and ultimately inhibit the continued growth of tumor cells, reverse a series of malignant symptoms caused by this, so that patients gradually return to a healthy state of the body.
Address: Room 502, 1043 HaLei Road, Pudong New Area, Shanghai, China
Building 7, Lane 908, Ziping Road, Pudong New Area, Shanghai, China
Tel. + 86 21 5835 6573